rvalles writes: "MIT Lincoln Laboratory researchers developed and tested a revolutionary antiviral which activates apoptosis in cells infected with viral dsRNA. It's called DRACO (Double-stranded RNA [dsRNA] Activated Caspase Oligomerizer) and it's been developed as part of a program called PANACEA (Pharmacological Augmentation of Nonspecific Anti-pathogen Cellular Enzymes and Activities). It should be effective against almost if not all viruses, so it's likely going to entirely change the way we deal with viral infection."
Some programming languages manage to absorb change, but withstand progress.
-- Epigrams in Programming, ACM SIGPLAN Sept. 1982